Mareye Voortman1,2,3, Jolanda De Vries3,4,5, Celine M R Hendriks1,3, Marjon D P Elfferich3, Petal A H M Wijnen3,6, Marjolein Drent1,3,7. 1. ILD Center of Excellence, Department of Pulmonology, St. Antonius Hospital, Nieuwegein, The Netherlands. 2. Department of Pulmonology, Division of Heart & Lungs, University Medical Centre Utrecht, The Netherlands. 3. ild care foundation research team, Ede, The Netherlands. 4. Department of Medical Psychology, Elisabeth-TweeSteden Hospital Tilburg, Tilburg, The Netherlands. 5. Department of Medical and Clinical Psychology, Tilburg University, Tilburg, The Netherlands. 6. Central Diagnostic Laboratory, Maastricht University Medical Centre, Maastricht, The Netherlands. 7. Department of Pharmacology and Toxicology, FHML, Maastricht University, Maastricht, The Netherlands.
Abstract
BACKGROUND: Cognitive failure is associated with memory and concentration problems. Previously, a prevalence of one third was found in a general sarcoidosis population. The aim of this study was to assess if neurosarcoidosis patients are at higher risk for developing everyday cognitive failure using the Cognitive Failure Questionnaire (CFQ) and to determine what factors were associated with cognitive failure. METHODS: A cross-sectional web-based survey was conducted from April to May 2017 in a national sample of neurosarcoidosis patients. The survey asked about complaints and included 3 questionnaires (Fatigue Assessment Scale [FAS], Small Fiber Neuropathy Screening List [SFNSL] and CFQ. Data were compared to a general sarcoidosis population. RESULTS: Of the 152 patients who completed the survey, 131 had neurosarcoidosis. The mean CFQ score was significantly higher in the neurosarcoidosis (45.6±20.7) compared to the general sarcoidosis population (36.2±15.9; p< 0.0001). High CFQ scores (≥43) were found in 55.7% and 33.9%, respectively (p<0.0001). The FAS score (OR 21.4) and SFNSL score (OR 4.3) were the strongest positive predictors of a high CFQ score. CONCLUSION: Cognitive failure is a significant problem in neurosarcoidosis. More than half of the patients reported cognitive deficits, compared to one third of a general sarcoidosis population. Fatigue and small fiber neuropathy play a role in cognitive failure. Copyright:
BACKGROUND: Cognitive failure is associated with memory and concentration problems. Previously, a prevalence of one third was found in a general sarcoidosis population. The aim of this study was to assess if neurosarcoidosis patients are at higher risk for developing everyday cognitive failure using the Cognitive Failure Questionnaire (CFQ) and to determine what factors were associated with cognitive failure. METHODS: A cross-sectional web-based survey was conducted from April to May 2017 in a national sample of neurosarcoidosis patients. The survey asked about complaints and included 3 questionnaires (Fatigue Assessment Scale [FAS], Small Fiber Neuropathy Screening List [SFNSL] and CFQ. Data were compared to a general sarcoidosis population. RESULTS: Of the 152 patients who completed the survey, 131 had neurosarcoidosis. The mean CFQ score was significantly higher in the neurosarcoidosis (45.6±20.7) compared to the general sarcoidosis population (36.2±15.9; p< 0.0001). High CFQ scores (≥43) were found in 55.7% and 33.9%, respectively (p<0.0001). The FAS score (OR 21.4) and SFNSL score (OR 4.3) were the strongest positive predictors of a high CFQ score. CONCLUSION: Cognitive failure is a significant problem in neurosarcoidosis. More than half of the patients reported cognitive deficits, compared to one third of a general sarcoidosis population. Fatigue and small fiber neuropathy play a role in cognitive failure. Copyright:
Authors: Daniel A Culver; Manuel L Ribeiro Neto; Brandon P Moss; Mary A Willis Journal: Semin Respir Crit Care Med Date: 2017-07-27 Impact factor: 3.119
Authors: M Drent; R M Wirnsberger; M H Breteler; L M Kock; J de Vries; E F Wouters Journal: Sarcoidosis Vasc Diffuse Lung Dis Date: 1998-03 Impact factor: 0.670
Authors: J P Zajicek; N J Scolding; O Foster; M Rovaris; J Evanson; I F Moseley; J W Scadding; E J Thompson; V Chamoun; D H Miller; W I McDonald; D Mitchell Journal: QJM Date: 1999-02
Authors: Sandrine Indart; Jacques Hugon; Pierre Jean Guillausseau; Alice Gilbert; Julien Dumurgier; Claire Paquet; Damien Sène Journal: Medicine (Baltimore) Date: 2017-04 Impact factor: 1.889
Authors: Orla Moriarty; Nancy Ruane; David O'Gorman; Chris H Maharaj; Caroline Mitchell; Kiran M Sarma; David P Finn; Brian E McGuire Journal: Front Behav Neurosci Date: 2017-06-13 Impact factor: 3.558